This week’s AI in Healthcare and Digital Health update highlights randomized trials, big-platform partnerships, product integrations, funding moves, workflow tools, wearable diagnostics, and patient-facing apps—plus more.
In Today’s Newsletter
Dive deeper
In Today’s Newsletter
🧭 Pyx Health launches AI navigator for social needs [1] [18 Nov 2025]
Context: OBBBA adds monthly work-requirement proofs, risking coverage loss for millions.
Key point: Pyx’s agentic AI guides members to transportation, food and housing, and helps document work requirements.
Implication: Access programs: May expand screening, initiation, and follow-up at scale.
🩺 Sweetch automated DPP matches human coaching in JAMA RCT [2] [20 Nov 2025]
Context: 3-year NIH-funded RCT, n=368 adults with prediabetes, Johns Hopkins lead.
Key point: AI arm showed ~93% initiation and ~64% completion with equivalent clinical outcomes to CDC-recognized coaching.
Implication: Clinical topline/efficacy: May influence prescriber choice and payer reviews pending full data.
❤️ AHA startups spotlight AI for vascular risk and glucose [3] [17 Nov 2025]
https://www.fiercebiotech.com/medtech/startups-aha-tout-innovative-tech-tracking-heart-brain-health
Context: MedTech Innovator showcase at AHA Scientific Sessions.
Key point: Kelvin Health thermal imaging for perfusion, LightHearted AI neck laser biomarker capture, SynchNeuro EEG-based glucose with ML.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
🧠 Philips integrates Cortechs.ai NeuroQuant into MR Smart Reading (WIP) [4] [19 Nov 2025]
Context: Integration planned within Smart Reading, existing availability on Philips Advanced Visualization Workspace.
Key point: Targets inline brain volumetry for AD, MS, neuro-oncology, but marked as work in progress with no assured market availability.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
✨ Oddity Tech debuts Methodiq tele-derm with AI skin analysis [5] [19 Nov 2025]
Context: Oddity’s third brand, focused on acne, hyperpigmentation, eczema.
Key point: Computer vision tracking, clinician loop, Rx and OTC options, cash-pay only, 28 core products at launch.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
🎙️ ESC Digital & AI Summit showcases stethoscope-via-phone and voice HF [6] [21 Nov 2025]
https://www.miragenews.com/smartphone-stethoscopes-ai-shine-at-esc-summit-1575465/
Context: Berlin program highlights Theodor Health smartphone stethoscope, Noah Labs voice HF monitoring, Epicardio CSP training, PocDoc screening.
Key point: Multiple AI tools targeting rapid CVD detection and training, with CE/FDA plans.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
🏠 TytoCare integrates with Teladoc 24/7 Care and Primary360 in 2026 [7] [18 Nov 2025]
Context: Integration to select customers starting 2026.
Key point: Adds remote physical exams and FDA-cleared AI Lung Sounds Suite to Teladoc workflows.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
🧾 FDA clearances roundup: AI, wearables, robotics [8] [21 Nov 2025]
https://hitconsultant.net/2025/11/21/11-recent-fda-clearances-you-need-to-know/
Context: Multiple devices cleared across cardiology, neuro, ortho, diabetes, wounds.
Key point: Highlights include Hexoskin HMS, RapidAI Aortic, Circle CVI plaque, Bunkerhill MAC, QuantalX Delphi-MD De Novo, Magstim pain, ZB ROSA Knee, Levita pediatric, MMI IDE in AD, Rapid Nexus Hemastyl, Tandem Mobi Android.
Implication: Regulatory/generics: Introduces competition that may affect pricing and formulary access.
🚑 AI ECG “Queen of Hearts” boosts STEMI triage accuracy [9] [19 Nov 2025]
Context: Multisite US analysis, 1,000+ suspected activations, 2020–2024 data.
Key point: AI detected more true STEMI on initial ECG and cut false positives vs standard triage.
Implication: Clinical topline/efficacy: May influence prescriber choice and payer reviews pending full data.
🔊 A.CURE voice-based HF screening targets Korea seniors, hospitals [10] [19 Nov 2025]
https://biz.chosun.com/en/en-industry/2025/11/19/P26KF6YRUJFEZB33IABPKUNSBM/
Context: “Heart to Voice” classifies HF risk from speech, phase-two trial underway.
Key point: Reports ~90% accuracy to date, aims for MFDS approval in 2H next year and broader Asia-US expansion.
Implication: Observational/RWE: Could inform practice and payer discussions, interpretation depends on design and confounding control.
🧪 Function Health raises $298M, unveils Medical Intelligence Lab [11] [19 Nov 2025]
https://www.lqventures.com/lucid-diligence-brief-function-health-raises-298m-series-b-at-2-5b/
Context: Series B at $2.5B valuation, post-Ezra acquisition for fast MRI/CT.
Key point: Clinician-guided AI layer across labs, imaging, wearables, with cash-pay model and scaling via Quest and MRI sites.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
⚖️ GoodRx launches weight-loss telehealth with GLP-1 discounts [12] [17 Nov 2025]
Context: Membership $39 until 1 Feb 2026, then $119, drugs billed separately.
Key point: $199 first two months for lower-dose Ozempic/Wegovy, no compounded meds, leverages retail pharmacy ties.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
☁️ Qure.ai partners with Microsoft to scale lung cancer AI in US [13] [20 Nov 2025]
Context: Integration into Precision Imaging Network.
Key point: Suite covers detection, quant, longitudinal tracking, with LLM-augmented workflows for MDTs.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
🎞️ Study: short-video platforms drive health info seeking via design cues [14] [20 Nov 2025]
https://journals.sagepub.com/doi/10.1177/20552076251394619
Context: Mixed methods, 566 surveys, 30 interviews.
Key point: Visual appeal and interactivity boost perceived usefulness and ease, increasing intent and behavior; health consciousness alone did not.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
📱 PLOS: App fatigue needs consolidation and “meet people where they are” [15] [21 Nov 2025]
https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001107
Context: Perspective on overload from fragmented mHealth.
Key point: Push for gateway platforms and embedding care in WhatsApp-like channels with layered privacy.
Implication: Access programs: May expand screening, initiation, and follow-up at scale.
⌚ Wearable HR + symptoms improve Long COVID detection to ROC-AUC 95.1% [16] [20 Nov 2025]
https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001093
Context: n=126 with acute COVID, ML on HR features plus symptoms.
Key point: Combined model outperformed symptoms-only by ~5% ROC-AUC and PR-AUC.
Implication: Clinical topline/efficacy: May influence prescriber choice and payer reviews pending full data.
🧮 npj: Round-number clinical thresholds can distort risk [17] [21 Nov 2025]
https://www.nature.com/articles/s41746-025-02079-y
Context: Glass-box ML across ICU datasets, MIMIC.
Key point: Detects discontinuities and paradoxes from thresholded practice, argues for dynamic reassessment.
Implication: Observational/RWE: Could inform practice and payer discussions, interpretation depends on study design and confounding control.
🍬 Review: AI + wearables in T2D management, promise and gaps [18] [18 Nov 2025]
https://www.nature.com/articles/s41746-025-02036-9
Context: Systematic review of 60 studies.
Key point: Strong potential for prediction and automation, but diversity, data quality, and interpretability remain limits.
Implication: Observational/RWE: Could inform practice and payer discussions, interpretation depends on study design and confounding control.
📱 FibriCheck smartphone AF detection validated multicenter [20] [20 Nov 2025]
https://www.nature.com/articles/s41746-025-02059-2
Context: 236 subjects, 10 phone models, ECG reference.
Key point: Accuracy 98.5%, sensitivity 96.3%, specificity 99.3%, mitigations for dark skin tone and BMI via technician verification.
Implication: Clinical topline/efficacy: May influence prescriber choice and payer reviews pending full data.
🤖 Pakistan trial of “My Diabetes Care” chatbot shows usability, early signals [21] [18 Nov 2025]
https://www.nature.com/articles/s41598-025-24172-8
Context: Rural clinics, n=200, explainable ANN + conversational agent.
Key point: 95% test accuracy, ~89% query resolution, small HbA1c reductions, high SUS scores.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
🌬️ Smartphone auscultation AI screens for AECOPD at AUC 0.955 [22] [21 Nov 2025]
https://www.nature.com/articles/s41746-025-02086-z
Context: Multi-center China development with cost-effectiveness modeling.
Key point: Audio-only approach for novice users, projected per-capita net savings with high probability of positive returns.
Implication: Access programs: May expand screening, initiation, and follow-up at scale.
🧒 ML clusters pediatric obesity/MetS into age-specific subtypes [23] [19 Nov 2025]
https://www.nature.com/articles/s41598-025-24524-4
Context: Iranian CASPIAN datasets, GMM clustering by age bands.
Key point: 6–7 phenotypes per band, revealing non-intuitive risk profiles, internal validation only.
Implication: Observational/RWE: Could inform practice and payer discussions, interpretation depends on study design and confounding control.
✋ UCSD noise-tolerant wearable enables gesture robot control in motion [24] [17 Nov 2025]
https://interestingengineering.com/innovation/ai-wearable-gesture-control-noise-tolerant
Context: Stretchable sensors plus deep learning denoise engine.
Key point: Reliable commands under running, vibration, simulated ocean conditions.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
🧠 Industry pulse: founders say Perplexity “most likely to fail” [25] [17 Nov 2025]
https://decrypt.co/348999/survey-ai-founders-perplexity-ai-giant-most-likely-to-fail
Context: Cerebral Valley survey of 300+ insiders.
Key point: Lawsuits and scraping claims weigh; Anthropic preferred for enterprise traction.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
💬 Meta-analysis: patients often rate AI replies as more empathic than clinicians [26] [16 Nov 2025]
Context: 15 studies, 2,164 live interactions dataset included.
Key point: AI typically scored higher on written empathy, dermatology an outlier.
Implication: DTC/telehealth: Could streamline initiation and adherence via remote prescribing and logistics.
🧩 Teva launches “Rise” open innovation platform, 7 challenges [27] [19 Nov 2025]
Context: Global program aligned to Pivot to Growth, with pilots and scale across Teva operations.
Key point: Calls span AI protocol design, predictive maintenance, quality risk, resource allocation, patient experience.
Implication: Partnerships/BD: Signals pipeline investment and modality expansion.
Why it matters
-
AI is moving from triage to end-to-end disease pathways, from lung cancer MDT workflows [13] to COPD audio screening at the edge [22].
-
Virtual care is adding diagnostics, blending devices and FDA-cleared AI, as TytoCare-Teladoc and smartphone AF tools show [7][20].
-
Economic levers are shifting via FDA clearances and DPP automation, lowering barriers for scale and decentralized trials [2][8].
-
UX and trust drive adoption: visual design and consolidated platforms reduce app fatigue and boost engagement in real-world settings [14][15].
-
Caution flags remain on regulatory status, external validation, and equity, especially across skin tones, BMI, and diverse cohorts [18][20][22].
🚀 Accelerate your success. Contact us now
📂 Explore our case studies. See examples of our work.
💡 Read our insights. Learn from our latest reports and analysis
🎬 Watch on YouTube. Subscribe and never miss a video.
🧰 See our full range of services. Discover how we can help you.
📚 Find your one-stop page for the full AI and Digital Health archive.
FAQ
What exactly did Philips and Cortechs.ai announce, and when could it be used in routine MRI?
Philips plans to embed NeuroQuant into Smart Reading for inline quantitative brain MRI, noted as a work in progress with no assured market availability by region as of 19 Nov 2025. NeuroQuant remains available on Philips Advanced Visualization Workspace today [4].
Did Sweetch’s AI program truly match human coaching in a head-to-head trial?
Yes, a 3-year NIH-funded RCT in JAMA reported equivalent clinical outcomes versus CDC-recognized human coaching and higher initiation and completion in the AI arm. Technical endpoints beyond engagement were not detailed in the summary [2].
How will Teladoc clinicians use TytoCare’s AI lung sounds?
Beginning in 2026 for selected customers, Teladoc’s 24/7 Care and Primary360 teams can incorporate TytoCare device findings, including FDA-cleared AI to classify common abnormal lung sounds, into remote exams and chronic care workflows [7].
What advantage does FibriCheck have versus other AF apps?
In a multicenter validation, FibriCheck achieved high accuracy across phones and comorbidities, and offered technician verification that improved sensitivity in darker skin tones and higher BMI, addressing known PPG bias issues [20].
What does the Qure.ai–Microsoft tie-up change for US hospitals?
Qure’s detection, quantification, and longitudinal tracking tools will be available through Microsoft’s Precision Imaging Network, easing deployment and integration for multidisciplinary lung cancer care teams [13].
Is Function Health’s new “Medical Intelligence Lab” regulated AI?
Function describes a clinician-guided AI layer spanning labs, imaging, records, and wearables. Specific AI imaging components from Ezra have FDA 510(k) clearances, while broader MI features are positioned as decision support, not diagnostic replacements [11].
Entities / Keywords
Pyx Health, OBBBA, social determinants; Sweetch Health, JAMA DPP; MedTech Innovator, Kelvin Health, LightHearted AI, SynchNeuro; Philips, Cortechs.ai, NeuroQuant, Smart Reading; Oddity Tech, Methodiq; ESC Digital & AI Summit, Theodor Health, Noah Labs, Epicardio, PocDoc; TytoCare, Teladoc; Hexoskin, RapidAI, Circle CVI, Bunkerhill Health, QuantalX, Magstim, Zimmer Biomet, Levita Magnetics, MMI, Rapid Nexus, Tandem Diabetes; UC Davis, Queen of Hearts AI ECG; A.CURE; Function Health, Ezra; GoodRx, Wegovy, Ozempic; Qure.ai, Microsoft Precision Imaging Network; SAGE short video TAM/HBM; PLOS app fatigue; PLOS Long COVID wearables; npj thresholds bias; npj AI+wearables T2D review; FibriCheck PPG AF; Scientific Reports My Diabetes Care chatbot; npj COPD smartphone auscultation; Scientific Reports pediatric obesity clustering; UCSD gesture wearable; Decrypt Perplexity survey; AI empathy meta-analysis; Teva Rise open innovation.
References
-
https://www.fiercebiotech.com/medtech/startups-aha-tout-innovative-tech-tracking-heart-brain-health
-
https://www.miragenews.com/smartphone-stethoscopes-ai-shine-at-esc-summit-1575465/
-
https://hitconsultant.net/2025/11/21/11-recent-fda-clearances-you-need-to-know/
-
https://biz.chosun.com/en/en-industry/2025/11/19/P26KF6YRUJFEZB33IABPKUNSBM/
-
https://www.lqventures.com/lucid-diligence-brief-function-health-raises-298m-series-b-at-2-5b/
-
https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001107
-
https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001093
- https://www.nature.com/articles/s41598-025-24172-8
-
https://interestingengineering.com/innovation/ai-wearable-gesture-control-noise-tolerant
-
https://decrypt.co/348999/survey-ai-founders-perplexity-ai-giant-most-likely-to-fail